Castle Biosciences, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1281555,
"name": "Castle Biosciences, Inc.",
"stock_name": "Castle Biosciences, Inc.",
"full_name": "Castle Biosciences, Inc.",
"name_url": "stocks-analysis/castle-biosciences-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "39.62",
"chg": 0.52,
"chgp": "1.33%",
"dir": 1,
"prev_price": "39.10",
"mcapval": "697.94",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2325,
"indexname": "S&P 500",
"isin": "US14843C1053",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "332.46 k",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/castle-biosciences-inc-1281555-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Castle Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations",
"link": "https://www.marketsmojo.com/news/stocks-in-action/castle-biosciences-inc-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-stock-fluctuations-3652149",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CastleBioscienc_technicaldot_3652149.png",
"date": "2025-10-28 15:59:59",
"description": "Castle Biosciences, Inc. has recently adjusted its technical trends, reflecting changes in performance indicators. The stock has shown mixed results, outperforming the S&P 500 over the past week but declining year-to-date and over five years. These trends underscore the company's market position and the need for continuous evaluation."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3651333",
"imagepath": "",
"date": "2025-10-28 11:40:43",
"description": "As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The key indicators driving this bullish stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. Additionally, the On-Balance Volume (OBV) is bullish on both weekly and monthly charts. The KST shows a mixed signal with weekly bullishness but monthly bearishness, while Dow Theory indicates a mildly bullish stance on both weekly and monthly timeframes. There is no available return data to compare the company's performance against the S&P 500...."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3647787",
"imagepath": "",
"date": "2025-10-27 11:51:53",
"description": "As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating strong upward momentum. Daily moving averages also support a bullish stance. However, the monthly KST is bearish, which suggests some caution. The Dow Theory shows a mildly bullish stance on both weekly and monthly time frames. Overall, the indicators point to a bullish sentiment, albeit with some mixed signals on the monthly KST. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3646320",
"imagepath": "",
"date": "2025-10-26 11:26:31",
"description": "As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators supporting this view. The MACD is bullish on the weekly timeframe, and Bollinger Bands are bullish on both weekly and monthly timeframes. The daily moving averages also indicate a bullish trend. However, the KST shows a bearish signal on the monthly timeframe, which suggests some caution. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 10.70% and 8.12% respectively, while it has underperformed over longer periods such as year-to-date and one year. Overall, the bullish indicators suggest a positive outlook in the short term, despite mixed longer-term performance...."
},
{
"title": "Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout",
"link": "https://www.marketsmojo.com/news/stocks-in-action/castle-biosciences-forms-golden-cross-signaling-potential-bullish-breakout-3607914",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/CastleBioscienc_goldencross_3607914.png",
"date": "2025-10-09 16:50:26",
"description": "Castle Biosciences, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock rose 2.92% today, contrasting with the S&P 500's decline. Despite a challenging year, recent technical indicators suggest a possible positive trend in investor sentiment for the company."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3558352",
"imagepath": "",
"date": "2025-09-23 11:19:29",
"description": "As of 19 September 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly chart. Moving averages are mildly bearish on the daily timeframe, which contrasts with the overall mildly bullish trend. The KST is bullish weekly but bearish monthly, and the Dow Theory indicates no trend weekly but mildly bullish monthly. Overall, the technical stance is mildly bullish, driven by the weekly MACD and Bollinger Bands, despite some bearish indicators in the monthly metrics. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3552205",
"imagepath": "",
"date": "2025-09-22 18:05:49",
"description": "As of 19 September 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD and Bollinger Bands indicate bullish momentum, while the daily moving averages suggest a mildly bearish stance. The KST is bullish on a weekly basis but bearish monthly, and Dow Theory shows a mixed signal with a mildly bearish weekly and mildly bullish monthly outlook. The stock has outperformed the S&P 500 over the past week and month, returning 13.96% and 22.66% respectively, but has underperformed over longer periods, notably with a -20.05% return over the past year compared to the S&P 500's 16.64%. Overall, the current technical stance is mildly bullish, supported by recent positive momentum indicators...."
},
{
"title": "Is Castle Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-technically-bullish-or-bearish-3546601",
"imagepath": "",
"date": "2025-09-20 19:36:41",
"description": "As of 10 September 2025, the technical trend for Castle Biosciences, Inc. has changed from sideways to mildly bearish. The weekly MACD is bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are mildly bearish, while the weekly KST is bullish and the monthly KST is bearish. The Dow Theory shows a mildly bearish stance on the weekly chart and a mildly bullish stance on the monthly chart. The OBV is mildly bullish on both weekly and monthly time frames. \n\nIn terms of performance, the stock has returned 14.11% over the past month compared to the S&P 500's 2.33%, but it has underperformed significantly over longer periods, with a year-to-date return of -11.97% versus the S&P 500's 12.22%. Overall, the current stance is mildly bearish, with key indicators reflecting mixed signals across different time frames...."
},
{
"title": "Is Castle Biosciences, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-castle-biosciences-inc-overvalued-or-undervalued-3543140",
"imagepath": "",
"date": "2025-09-20 18:11:45",
"description": "As of 5 May 2025, the valuation grade for Castle Biosciences, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, given its current Price to Book Value of 1.15, an EV to EBITDA ratio of 8.54, and a negative ROCE of -7.81%. In comparison to peers, Castle's EV to EBITDA ratio is significantly less favorable than that of Atrion Corp., which has a ratio of 26.2211, and Silk Road Medical, Inc., with a ratio of -18.1243.\n\nThe stock has underperformed relative to the S&P 500, with a year-to-date return of -11.97% compared to the index's 12.22%, and a 1-year return of -22.73% versus 17.14% for the S&P 500. This trend reinforces the notion that Castle Biosciences, Inc. is overvalued in the current market context...."
}
],
"total": 13,
"sid": "1281555",
"stock_news_url": "https://www.marketsmojo.com/news/castle-biosciences-inc-1281555"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Castle Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations

2025-10-28 15:59:59

Castle Biosciences, Inc. has recently adjusted its technical trends, reflecting changes in performance indicators. The stock has shown mixed results, outperforming the S&P 500 over the past week but declining year-to-date and over five years. These trends underscore the company's market position and the need for continuous evaluation.

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-10-28 11:40:43

As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The key indicators driving this bullish stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. Additionally, the On-Balance Volume (OBV) is bullish on both weekly and monthly charts. The KST shows a mixed signal with weekly bullishness but monthly bearishness, while Dow Theory indicates a mildly bullish stance on both weekly and monthly timeframes. There is no available return data to compare the company's performance against the S&P 500....

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-10-27 11:51:53

As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating strong upward momentum. Daily moving averages also support a bullish stance. However, the monthly KST is bearish, which suggests some caution. The Dow Theory shows a mildly bullish stance on both weekly and monthly time frames. Overall, the indicators point to a bullish sentiment, albeit with some mixed signals on the monthly KST. Multi-period return data is not available for comparison with the S&P 500....

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-10-26 11:26:31

As of 24 October 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators supporting this view. The MACD is bullish on the weekly timeframe, and Bollinger Bands are bullish on both weekly and monthly timeframes. The daily moving averages also indicate a bullish trend. However, the KST shows a bearish signal on the monthly timeframe, which suggests some caution. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 10.70% and 8.12% respectively, while it has underperformed over longer periods such as year-to-date and one year. Overall, the bullish indicators suggest a positive outlook in the short term, despite mixed longer-term performance....

Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout

2025-10-09 16:50:26

Castle Biosciences, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock rose 2.92% today, contrasting with the S&P 500's decline. Despite a challenging year, recent technical indicators suggest a possible positive trend in investor sentiment for the company.

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-09-23 11:19:29

As of 19 September 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly chart. Moving averages are mildly bearish on the daily timeframe, which contrasts with the overall mildly bullish trend. The KST is bullish weekly but bearish monthly, and the Dow Theory indicates no trend weekly but mildly bullish monthly. Overall, the technical stance is mildly bullish, driven by the weekly MACD and Bollinger Bands, despite some bearish indicators in the monthly metrics. Multi-period return data is not available for comparison with the S&P 500....

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-09-22 18:05:49

As of 19 September 2025, the technical trend for Castle Biosciences, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD and Bollinger Bands indicate bullish momentum, while the daily moving averages suggest a mildly bearish stance. The KST is bullish on a weekly basis but bearish monthly, and Dow Theory shows a mixed signal with a mildly bearish weekly and mildly bullish monthly outlook. The stock has outperformed the S&P 500 over the past week and month, returning 13.96% and 22.66% respectively, but has underperformed over longer periods, notably with a -20.05% return over the past year compared to the S&P 500's 16.64%. Overall, the current technical stance is mildly bullish, supported by recent positive momentum indicators....

Is Castle Biosciences, Inc. technically bullish or bearish?

2025-09-20 19:36:41

As of 10 September 2025, the technical trend for Castle Biosciences, Inc. has changed from sideways to mildly bearish. The weekly MACD is bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are mildly bearish, while the weekly KST is bullish and the monthly KST is bearish. The Dow Theory shows a mildly bearish stance on the weekly chart and a mildly bullish stance on the monthly chart. The OBV is mildly bullish on both weekly and monthly time frames. In terms of performance, the stock has returned 14.11% over the past month compared to the S&P 500's 2.33%, but it has underperformed significantly over longer periods, with a year-to-date return of -11.97% versus the S&P 500's 12.22%. Overall, the current stance is mildly bearish, with key indicators reflecting mixed signals across different time frames....

Is Castle Biosciences, Inc. overvalued or undervalued?

2025-09-20 18:11:45

As of 5 May 2025, the valuation grade for Castle Biosciences, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, given its current Price to Book Value of 1.15, an EV to EBITDA ratio of 8.54, and a negative ROCE of -7.81%. In comparison to peers, Castle's EV to EBITDA ratio is significantly less favorable than that of Atrion Corp., which has a ratio of 26.2211, and Silk Road Medical, Inc., with a ratio of -18.1243. The stock has underperformed relative to the S&P 500, with a year-to-date return of -11.97% compared to the index's 12.22%, and a 1-year return of -22.73% versus 17.14% for the S&P 500. This trend reinforces the notion that Castle Biosciences, Inc. is overvalued in the current market context....

View All News